VASCULAR

Axiostat - 100% Chitosan Haemostatic Dressing on Transfemoral Interventional Cardiology Procedure

Center

  • Seth Sukhlal Karnani Medical Hospital, Kolkata-India
  • Institute of Neurosciences, Kolkata-India
Patient details44 years , Male41 years , Male55 years , Male
Patient historyDiabetes & HypertensionNo Diabetes & no HypertensionDiabetes & no Hypertension
ProcedurePTCADSAPTCA
Heparin dosage8000 IU-8000 IU
Sheath size6F5F6F
Loading doseClopidogrel 300 mg-Clopidogrel 300 mg
Axiostat VariantV55V55V55
Average time taken to achieve haemostasis6 mins5 mins5 mins
VASCULAR

The sheath was removed carefully from the access site

VASCULAR

Axiostat was placed on the puncture from where the blood was oozing out

VASCULAR

The pressure was applied firmly on the puncture location for 5 mins

VASCULAR

Axiostat was removed by irrigating with saline & disposed later.Puncture site was cleaned

Result

Patient Outcome with AxiostatEase of ApplicationEase of RemovalAntimicrobial barrierAdherence to WoundConformability of DressingPatient dressing
Excellent
Good
Fair
Poor

Discussion

  • The average time to achieve haemostasis in PTCA patients was 5.5mins (n=2), whereas, for the single DSA patient, haemostasis was achieved in 5mins.
  • The haemostasis time in both groups was significantly shorter than the conventional method of applying manual compression
    with cotton gauze, which usually requires around 20 mins to achieve haemostasis.
  • No re-bleeding from puncture sites was observed during the observation for additional 2-3 hours after removing the
    manual compression. Similarly, the puncture sites showed no rebleeding, skin irritation, swelling, vascular complication,
    allergy after the removal of Axiostat.
  • Further, there was no incidence of device-related bleeding complications during 5 days after the surgery.
    Overall, Axiostat was also found to be an excellent haemostat dressing in patients undergoing transfemoral interventional
    cardiology procedures.